PRESCRIPTION MONITORING PROGRAM USING THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM (CPMRS)

Similar documents
Delegator Dashboard User Guide

New Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP

Frequently Asked Questions

Nevada. Contact Information. State Registrant Totals and Population

Georgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF FLORIDA PANAMA CITY DIVISION COUNTS ONE THROUGH ONE HUNDRED. A.

Prescription Monitoring Programs - Legislative Trends and Model Law Revision

Ohio. Contact Information. State Registrant Totals and Population

Prescription Monitoring Program:

Mississippi. Contact Information. State Registrant Totals and Population

Alaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP

Office of Inspector General

Prescription Drug Monitoring Program (PDMP)

Puerto Rico. Contact Information. State Registrant Totals and Population. PDMP name: PR PDMP

District of Columbia Prescription Drug Monitoring Program

Massachusetts. Contact Information. State Registrant Totals and Population. PDMP name: MA Prescription Monitoring Program

Tennessee. Contact Information. State Registrant Totals and Population. PDMP name: CSMD

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

STATE OF TEXAS TEXAS STATE BOARD OF PHARMACY

Prescription Drug Monitoring Program (PDMP)

Colorado. Contact Information

Connecticut Department of Consumer Protection, Medical Marijuana Program

Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives

Michigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS

Massachusetts Prescription Monitoring Program

North Carolina. Contact Information. State Registrant Totals and Population. PDMP region: PDMP name: Agency responsible:

Kentucky. Kentucky Cabinet for Health and Family Services Office of Inspector General

Hydrocodone Prescribing and the New Texas PMP

Drug Diversion: Enforcement Trends, Investigation, & Prevention

Prescription Drug Monitoring Program (PDMP)

Building a Common REMS Platform: Use Case Guide for Prescriber Certification

Prescription Monitoring Program State Profiles - California

Prescription Drug Monitoring Program (PDMP) LOUISIANA. Information contained in this presentation is accurate as of September 2017

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016

Prescription Monitoring Program State Profiles - Illinois

Implementing Systems for Detection and Prevention of Drug Diversion

Frequently Asked Questions MN Prescription Monitoring Program (PMP)

PATIENT NOTICE. If you are already taking any of the above medications, your provider may want to talk to you about alternative treatments.

Prescription Monitoring Program State Profiles - Michigan

National Association of Boards of Pharmacy PMP Interconnect NABP

Prescriptive Authority in Oregon

South Carolina Reporting & Identification Prescription Tracking System (SCRIPTS)

Physicians receive incentives for eprescribing for Medicare patients; penalties are imposed for noncompliance.

Legal Issues in Managing Opioid Abuse. Gwen Dayton, JD

Interim Commissioner Lauren A. Smith and Members of the Public Health Council

Run Management Reports Tutorial

Technical Assistance Guide. Enhancing PDMPs: A Comparison of Changes 2010 to 2016

Evidence-Based Practices to Optimize Prescriber Use of PDMPs

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

Prescription Monitoring Program State Profiles - Texas

McConnell AFB Pharmacy Frequently Asked Questions

EMIRATES FOUNDATION USER MANUAL. Interns Manual

Maryland. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board

InstyMeds Prescription Writer Tutorial

Oklahoma. Contact Information. Office: Fax: Statistics

An Overview for Inpatient Pharmacies (e.g., hospitals, in-hospital hospices, and long-term care facilities that dispense for inpatient use)

PMIX ADVANCING PMP DATA SHARING THROUGH STANDARDIZATION AND INNOVATION CARL FLANSBAUM, DIRECTOR, NEW MEXICO PMP CO-CHAIR PMIX WORKING GROUP

RULES FOR STUDENT POSSESSION AND ADMINISTRATION OF ASTHMA, ALLERGY AND ANAPHYLAXIS MANAGEMENT MEDICATIONS OR OTHER PRESCRIPTION MEDICATIONS

AMENDMENT TO SENATE BILL 772. AMENDMENT NO.. Amend Senate Bill 772, AS AMENDED, by. replacing everything after the enacting clause with the following:

a remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.

Prescription Monitoring Program State Profiles - Pennsylvania

A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR.

SENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014

A Handbook to Help You Understand and Succeed in the Washington Health Professional Services (WHPS) Program

4.35 STUDENT MEDICATIONS

Eligible Professional Core Measure Frequently Asked Questions

MyRx: Final Report PREAMBLE Abstract 1.2 Previous Work Keywords INTRODUCTION 1.1 Overview

DC Board of Pharmacy and Pharmaceutical Control Update

The Wisconsin epdmp:

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT

Effective Date: 11/09 Policy Chronicle:

WIMCR and CCS FAQ Categories

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

On September 4, 2012, the evening shift supervisor called the

NEW MEXICO PRACTITIONER S MANUAL

Summer Webinar Series. The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018

Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.

MEANINGFUL USE TRAINING SCENARIOS GUIDE

Not if, but When: Drug Diversion in Hospitals. Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA

Medicare Advantage and Part D Compliance Training. 42 CFR Parts and

Transcribing Medicines for Adults Policy. Policy Register No:09076 Status: Public. NHSLA Risk Assessment standards

Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN

Pharmacy Law Home Study for Pharmacists and Pharmacy Technicians Preparing Your Pharmacy for a DEA Inspection

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 21.00: REGISTRATION OF OUTSOURCING FACILITIES. Section

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

Prescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18

-Health Update. Encounter Notification System (ENS) Celebrates Five Years! Welcome

OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS

Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory)

Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015

Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements

for more information visit GradLeaders.com

PHARMACEUTICALS AND MEDICATIONS

Pharmaceutical Diversion Prevention, Detection and Incident Response

Prescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness

Connecticut Early Childhood Professional Registry

Admission Medication History and Reconciliation Documentation. Froedtert Hospital, Milwaukee WI

How to Get the Most Out of Prescription Drug Monitoring Programs

Transcription:

PRESCRIPTION MONITORING PROGRAM USING THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM (CPMRS)

Presenters Connecticut Department of Consumer Protection, Prescription Monitoring Program Nana Kittiphane, HPA I & Xaviel Soto, Program Manager

Objectives Program Overview o Background o CPMRS Data o Connecticut Legislation Patient Queries - CPMRS (PMP AWARxE) o https://connecticut.pmpaware.net

Background In 2006, legislators enacted CGS: Section 21a-254 providing for a PMP. The PMP became fully operational in February 2008. July 1, 2008, the CPMRS went live. Funding through the U.S. Department of Justice (DOJ) and the U.S. Department of Health & Human Services (HHS)

CPMRS Data # of Controlled Substance Prescriptions/Year 6,300,000 6,200,000 6,100,000 6,000,000 5,900,000 6,064,563 6,249,637 2012 2013 2014 2015 5,800,000 5,700,000 5,829,240 5,990,233 5,600,000 # of Prescriptions/Year

# of Controlled Substance Prescriptions/County 2015

CPMRS Data Most Prescribed Controlled Substances - 2015 600000 500000 400000 300000 200000 Alprazolam Oxycodone & Acetaminophen Zolpidem Tartrate Clonazepam Lorazepam 100000 0 2015

What is the CPMRS? CT Prescription Monitoring and Reporting System Collection of prescription data for Schedule II-V drugs Data stored in centralized, relational database Data collection began in July 2008 Data submission o Over 600 in-state pharmacies o 400 out-of-state mail order and Internet pharmacies 3 years of accessible data

What Kind of Drugs Are Reported? SCHEDULE II Oxycontin, marijuana, methadone, morphine, Ritalin SCHEDULE III Lortab, Vicodin, testosterone, Tylenol with Codeine SCHEDULE IV Valium, Xanax, Darvocet-N100, Ambien SCHEDULE V Lomotil, Robitussin AC *Complete list of scheduled drugs is available at the U.S. Food and Drug Administration s (FDA) website.

Who Can Access Information? Prescribers for their patients only Delegates (licensed and unlicensed) Pharmacists for their patients only Authorized Law Enforcement/Regulatory Personnel may obtain information from the system only when there is an active investigation.

Mandatory Registration Public Act 13-172 (Effective 6/21/2013) Signed into law on June 21, 2013. Mandatory Reporting by prescribers dispensing controlled substances from their practice or facility All prescribers in possession of a Controlled Substance Practitioner (CSP) registration, will be required to register as a user with the Connecticut Prescription Monitoring and Reporting System (CPMRS) at https://connecticut.pmpaware.net/login.

Continue Public Act 13-172 (Effective 6/21/2013) Any prescribers who dispense controlled substances from their practice, or facility, etc., will be required to upload dispensing information into the CPMRS Data Collection website at https://pmpclearinghouse.net. No person or employer shall prohibit, discourage or impede a prescribing practitioner or pharmacist from requesting controlled substance prescription information. Identify other products or substances to be included in the electronic prescription drug monitoring program. Requires pharmacies to report weekly instead of twice a month.

Mandatory Usage Public Act 15-198 (Effective 10/01/2015) Prior to prescribing greater than a 72-hour supply of any controlled substance (Schedule II - V) to any patient, the prescribing practitioner or such practitioner's authorized agent who is also a licensed health care professional shall review the patient's records in the CPMRS at https://connecticut.pmpaware.net. Whenever a prescribing practitioner prescribes controlled substances for the continuous or prolonged treatment of any patient, such prescriber, or such prescriber's authorized agent who is also a licensed health care professional, shall review, not less than once every 90 days, the patient's records in the CPMRS.

June Special Session Public Act 15-5, Sec. 354 (Effective 10/01/2015) On and after July 1, 2016, each pharmacy, nonresident pharmacy, outpatient pharmacy in a hospital or institution, and dispenser shall report all controlled substance prescriptions dispensed immediately upon, but in no event later than the next business day after, dispensing such prescriptions. Collection website at https://pmpclearinghouse.net.

Public Act 16-43 (Effective 07/01/2016) Daily reporting will not apply to veterinary dispensaries. For veterinary dispensaries, dispensation reports are still due weekly. User roles in the CPMRS has been expanded to include both licensed and unlicensed delegates. Patient query must be conducted at least once a year for prescription of Schedule V nonnarcotic controlled substance, for the continuous or prolonged treatment of any patient, such prescribing practitioner, or such prescribing practitioner's authorized agent, shall review, not less than annually, the patient's records in such prescription drug monitoring program.

Connecticut Prescription Monitoring & Reporting System (CPMRS) Register to become a user. Log-in Page visit https://connecticut.pmpaware.net/ If first time user, click on Create an Account.

CPMRS Registration Page Registration Tutorial Required Fields

CPMRS Registration Page Not Complete Form Upload Required Documents

Include a government issued I.D. Card CPMRS Registration Page PMP Fax Number Have form notarized by a license notary Auto-Registration is now available in the CPMRS Sign and upload or fax the notarized form to DCP at (860) 622-2608.

CPMRS Login Page Login

CPMRS Home Page Prescriber /Pharmacist Dashboard Delegate Dashboard CPMRS Home Page

CPMRS Patient Request Tutorial Include First Name & Last Name. Check Partial Search You may change the time frame here Prescribers attest the information is for a patient they are providing treatment.

CPMRS Patient Report Patient s Name Summary PDF & Excel Prescriber Name & Address Pharmacy Name & Address

USE OF THE REPORT: Things You May Do The practitioner may: o Discuss the findings of the report, not the contents of the report, with; The patient, Another health care provider treating the patient A dispenser who has dispensed or will dispense medications to the patient

USE OF THE REPORT: Thing(s) You Can t Do You may NOT share the actual report with anyone not involved in the treatment of the patient.

Continue CPMRS Data The data is not perfect. The report is based on search criteria entered and data entered by the dispensing pharmacy. For more information on a prescription, contact the dispensing pharmacy or the prescriber.

CPMRS Request History Select Name Refresh & View Click to see results

CPMRS MyRx User DEA # Include Date Range

CPMRS MyRx PDF & Excel DEA # Patient Info

CPMRS - Features Existing Clinical Alerts (Threshold, MME/d, Opiod/Benzodiapine) Upcoming Prescriber Reports Mobile Application Patient Alerts

QUESTIONS?

Program Contact Information Presented By: Nana Kittiphane, HPA I Xaviel Soto, Program Manager Program Phone #: (860) 713-6073 Fax #: (860) 622-2608 Email: dcp.pmp@ct.gov DCP PMP Website: www.ct.gov/dcp/pmp CPMRS Website: https://connecticut.pmpaware.net PMP Clearinghouse: https://pmpclearinghouse.net.